Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with 192Ir, 60Co, and 169Yb HDR sources: A

Habib Safigholi, Dae Yup Han, Shahram Mashouf, Abraam Soliman, Ali S. Meigooni, Amir Owrangi, William Y. Song

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR brachytherapy sources, for various cervical cancer high-risk clinical target volumes (CTVHR). Materials and Methods: The novel DMBT tandem applicator has six peripheral grooves of 1.3-mm diameter along a 5.4-mm thick nonmagnetic tungsten alloy rod. Monte Carlo (MC) simulations were used to benchmark the dosimetric parameters of the 192Ir, 60Co, and 169Yb HDR sources in a water phantom against the literature data. 45 clinical cases that were treated using conventional tandem-and-ring applicators with 192Ir source (192Ir-T&R) were selected consecutively from intErnational MRI-guided BRAchytherapy in CErvical cancer (EMBRACE) trial. Then, for each clinical case, 3D dose distribution of each source inside the DMBT and conventional applicators were calculated and imported onto an in-house developed inverse planning optimization code to generate optimal plans. All plans generated by the DMBT tandem-and-ring (DMBT T&R) from all three sources were compared to the respective 192Ir-T&R plans. For consistency, all plans were normalized to the same CTVHR D90 achieved in clinical plans. The D2 cm3 for organs at risk (OAR) such as bladder, rectum, and sigmoid, and D90, D98, D10, V100, and V200 for CTVHR were calculated. Results: In general, plan quality significantly improved when a conventional tandem (Con.T) is replaced with the DMBT tandem. The target coverage metrics were similar across 192Ir-T&R and DMBT T&R plans with all three sources (P > 0.093). 60Co-DMBT T&R generated greater hot spots and less dose homogeneity in the target volumes compared with the 192Ir- and 169Yb-DMBT T&R plans. Mean OAR doses in the DMBT T&R plans were significantly smaller (P < 0.0084) than the 192Ir-T&R plans. Mean bladder D2 cm3 was reduced by 4.07%, 4.15%, and 5.13%, for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. Mean rectum (sigmoid) D2 cm3 was reduced by 3.17% (3.63%), 2.57% (3.96%), and 4.65% (4.34%) for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. The DMBT T&R plans with the 169Yb source generally resulted in the greatest OAR sparing when the CTVHR were larger and irregular in shape, while for smaller and regularly shaped CTVHR (<30 cm3), OAR sparing between the sources were comparable. Conclusions: The DMBT tandem provides a promising alternative to the Con.T design with significant improvement in the plan quality for various target volumes. The DMBT T&R plans generated with the three sources of varying energies generated superior plans compared to the conventional T&R applicators. Plans generated with the 169Yb-DMBT T&R produced best results for larger and irregularly shaped CTVHR in terms of OAR sparing. Thus, this study suggests that the combination of the DMBT tandem applicator with varying energy sources can work synergistically to generate improved plans for cervical cancer brachytherapy.

Original languageEnglish (US)
Pages (from-to)6538-6547
Number of pages10
JournalMedical Physics
Volume44
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Brachytherapy
Uterine Cervical Neoplasms
Organs at Risk
Therapeutics
Direction compound
Sigmoid Colon
Rectum
Urinary Bladder
Benchmarking
Tungsten

Keywords

  • Yb
  • Ir
  • Co
  • cervical cancer
  • direction modulated brachytherapy

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Direction modulated brachytherapy (DMBT) for treatment of cervical cancer : A planning study with 192Ir, 60Co, and 169Yb HDR sources: A. / Safigholi, Habib; Han, Dae Yup; Mashouf, Shahram; Soliman, Abraam; Meigooni, Ali S.; Owrangi, Amir; Song, William Y.

In: Medical Physics, Vol. 44, No. 12, 01.12.2017, p. 6538-6547.

Research output: Contribution to journalArticle

Safigholi, Habib ; Han, Dae Yup ; Mashouf, Shahram ; Soliman, Abraam ; Meigooni, Ali S. ; Owrangi, Amir ; Song, William Y. / Direction modulated brachytherapy (DMBT) for treatment of cervical cancer : A planning study with 192Ir, 60Co, and 169Yb HDR sources: A. In: Medical Physics. 2017 ; Vol. 44, No. 12. pp. 6538-6547.
@article{6b34caa5a42748de84ce68d50b508b76,
title = "Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with 192Ir, 60Co, and 169Yb HDR sources: A",
abstract = "Purpose: To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR brachytherapy sources, for various cervical cancer high-risk clinical target volumes (CTVHR). Materials and Methods: The novel DMBT tandem applicator has six peripheral grooves of 1.3-mm diameter along a 5.4-mm thick nonmagnetic tungsten alloy rod. Monte Carlo (MC) simulations were used to benchmark the dosimetric parameters of the 192Ir, 60Co, and 169Yb HDR sources in a water phantom against the literature data. 45 clinical cases that were treated using conventional tandem-and-ring applicators with 192Ir source (192Ir-T&R) were selected consecutively from intErnational MRI-guided BRAchytherapy in CErvical cancer (EMBRACE) trial. Then, for each clinical case, 3D dose distribution of each source inside the DMBT and conventional applicators were calculated and imported onto an in-house developed inverse planning optimization code to generate optimal plans. All plans generated by the DMBT tandem-and-ring (DMBT T&R) from all three sources were compared to the respective 192Ir-T&R plans. For consistency, all plans were normalized to the same CTVHR D90 achieved in clinical plans. The D2 cm3 for organs at risk (OAR) such as bladder, rectum, and sigmoid, and D90, D98, D10, V100, and V200 for CTVHR were calculated. Results: In general, plan quality significantly improved when a conventional tandem (Con.T) is replaced with the DMBT tandem. The target coverage metrics were similar across 192Ir-T&R and DMBT T&R plans with all three sources (P > 0.093). 60Co-DMBT T&R generated greater hot spots and less dose homogeneity in the target volumes compared with the 192Ir- and 169Yb-DMBT T&R plans. Mean OAR doses in the DMBT T&R plans were significantly smaller (P < 0.0084) than the 192Ir-T&R plans. Mean bladder D2 cm3 was reduced by 4.07{\%}, 4.15{\%}, and 5.13{\%}, for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. Mean rectum (sigmoid) D2 cm3 was reduced by 3.17{\%} (3.63{\%}), 2.57{\%} (3.96{\%}), and 4.65{\%} (4.34{\%}) for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. The DMBT T&R plans with the 169Yb source generally resulted in the greatest OAR sparing when the CTVHR were larger and irregular in shape, while for smaller and regularly shaped CTVHR (<30 cm3), OAR sparing between the sources were comparable. Conclusions: The DMBT tandem provides a promising alternative to the Con.T design with significant improvement in the plan quality for various target volumes. The DMBT T&R plans generated with the three sources of varying energies generated superior plans compared to the conventional T&R applicators. Plans generated with the 169Yb-DMBT T&R produced best results for larger and irregularly shaped CTVHR in terms of OAR sparing. Thus, this study suggests that the combination of the DMBT tandem applicator with varying energy sources can work synergistically to generate improved plans for cervical cancer brachytherapy.",
keywords = "Yb, Ir, Co, cervical cancer, direction modulated brachytherapy",
author = "Habib Safigholi and Han, {Dae Yup} and Shahram Mashouf and Abraam Soliman and Meigooni, {Ali S.} and Amir Owrangi and Song, {William Y.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1002/mp.12598",
language = "English (US)",
volume = "44",
pages = "6538--6547",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "12",

}

TY - JOUR

T1 - Direction modulated brachytherapy (DMBT) for treatment of cervical cancer

T2 - A planning study with 192Ir, 60Co, and 169Yb HDR sources: A

AU - Safigholi, Habib

AU - Han, Dae Yup

AU - Mashouf, Shahram

AU - Soliman, Abraam

AU - Meigooni, Ali S.

AU - Owrangi, Amir

AU - Song, William Y.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose: To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR brachytherapy sources, for various cervical cancer high-risk clinical target volumes (CTVHR). Materials and Methods: The novel DMBT tandem applicator has six peripheral grooves of 1.3-mm diameter along a 5.4-mm thick nonmagnetic tungsten alloy rod. Monte Carlo (MC) simulations were used to benchmark the dosimetric parameters of the 192Ir, 60Co, and 169Yb HDR sources in a water phantom against the literature data. 45 clinical cases that were treated using conventional tandem-and-ring applicators with 192Ir source (192Ir-T&R) were selected consecutively from intErnational MRI-guided BRAchytherapy in CErvical cancer (EMBRACE) trial. Then, for each clinical case, 3D dose distribution of each source inside the DMBT and conventional applicators were calculated and imported onto an in-house developed inverse planning optimization code to generate optimal plans. All plans generated by the DMBT tandem-and-ring (DMBT T&R) from all three sources were compared to the respective 192Ir-T&R plans. For consistency, all plans were normalized to the same CTVHR D90 achieved in clinical plans. The D2 cm3 for organs at risk (OAR) such as bladder, rectum, and sigmoid, and D90, D98, D10, V100, and V200 for CTVHR were calculated. Results: In general, plan quality significantly improved when a conventional tandem (Con.T) is replaced with the DMBT tandem. The target coverage metrics were similar across 192Ir-T&R and DMBT T&R plans with all three sources (P > 0.093). 60Co-DMBT T&R generated greater hot spots and less dose homogeneity in the target volumes compared with the 192Ir- and 169Yb-DMBT T&R plans. Mean OAR doses in the DMBT T&R plans were significantly smaller (P < 0.0084) than the 192Ir-T&R plans. Mean bladder D2 cm3 was reduced by 4.07%, 4.15%, and 5.13%, for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. Mean rectum (sigmoid) D2 cm3 was reduced by 3.17% (3.63%), 2.57% (3.96%), and 4.65% (4.34%) for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. The DMBT T&R plans with the 169Yb source generally resulted in the greatest OAR sparing when the CTVHR were larger and irregular in shape, while for smaller and regularly shaped CTVHR (<30 cm3), OAR sparing between the sources were comparable. Conclusions: The DMBT tandem provides a promising alternative to the Con.T design with significant improvement in the plan quality for various target volumes. The DMBT T&R plans generated with the three sources of varying energies generated superior plans compared to the conventional T&R applicators. Plans generated with the 169Yb-DMBT T&R produced best results for larger and irregularly shaped CTVHR in terms of OAR sparing. Thus, this study suggests that the combination of the DMBT tandem applicator with varying energy sources can work synergistically to generate improved plans for cervical cancer brachytherapy.

AB - Purpose: To evaluate plan quality of a novel MRI-compatible direction modulated brachytherapy (DMBT) tandem applicator using 192Ir, 60Co, and 169Yb HDR brachytherapy sources, for various cervical cancer high-risk clinical target volumes (CTVHR). Materials and Methods: The novel DMBT tandem applicator has six peripheral grooves of 1.3-mm diameter along a 5.4-mm thick nonmagnetic tungsten alloy rod. Monte Carlo (MC) simulations were used to benchmark the dosimetric parameters of the 192Ir, 60Co, and 169Yb HDR sources in a water phantom against the literature data. 45 clinical cases that were treated using conventional tandem-and-ring applicators with 192Ir source (192Ir-T&R) were selected consecutively from intErnational MRI-guided BRAchytherapy in CErvical cancer (EMBRACE) trial. Then, for each clinical case, 3D dose distribution of each source inside the DMBT and conventional applicators were calculated and imported onto an in-house developed inverse planning optimization code to generate optimal plans. All plans generated by the DMBT tandem-and-ring (DMBT T&R) from all three sources were compared to the respective 192Ir-T&R plans. For consistency, all plans were normalized to the same CTVHR D90 achieved in clinical plans. The D2 cm3 for organs at risk (OAR) such as bladder, rectum, and sigmoid, and D90, D98, D10, V100, and V200 for CTVHR were calculated. Results: In general, plan quality significantly improved when a conventional tandem (Con.T) is replaced with the DMBT tandem. The target coverage metrics were similar across 192Ir-T&R and DMBT T&R plans with all three sources (P > 0.093). 60Co-DMBT T&R generated greater hot spots and less dose homogeneity in the target volumes compared with the 192Ir- and 169Yb-DMBT T&R plans. Mean OAR doses in the DMBT T&R plans were significantly smaller (P < 0.0084) than the 192Ir-T&R plans. Mean bladder D2 cm3 was reduced by 4.07%, 4.15%, and 5.13%, for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. Mean rectum (sigmoid) D2 cm3 was reduced by 3.17% (3.63%), 2.57% (3.96%), and 4.65% (4.34%) for the 192Ir-, 60Co-, and 169Yb-DMBT T&R plans respectively. The DMBT T&R plans with the 169Yb source generally resulted in the greatest OAR sparing when the CTVHR were larger and irregular in shape, while for smaller and regularly shaped CTVHR (<30 cm3), OAR sparing between the sources were comparable. Conclusions: The DMBT tandem provides a promising alternative to the Con.T design with significant improvement in the plan quality for various target volumes. The DMBT T&R plans generated with the three sources of varying energies generated superior plans compared to the conventional T&R applicators. Plans generated with the 169Yb-DMBT T&R produced best results for larger and irregularly shaped CTVHR in terms of OAR sparing. Thus, this study suggests that the combination of the DMBT tandem applicator with varying energy sources can work synergistically to generate improved plans for cervical cancer brachytherapy.

KW - Yb

KW - Ir

KW - Co

KW - cervical cancer

KW - direction modulated brachytherapy

UR - http://www.scopus.com/inward/record.url?scp=85037836130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037836130&partnerID=8YFLogxK

U2 - 10.1002/mp.12598

DO - 10.1002/mp.12598

M3 - Article

C2 - 28940520

AN - SCOPUS:85037836130

VL - 44

SP - 6538

EP - 6547

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 12

ER -